A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Nebulized Ensifentrine in Healthy Chinese Subjects
Clinical trial NCT05758428 · COMPLETED
Trial details
- NCT number
- NCT05758428
- Sponsor
- Nuance Pharma (shanghai) Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2023-04-18
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.